TEVA, A potential both-sided inside day.It's really tough for TEVA investors since 2016, everything seems so bad for this generic drugs giant.
They finally got a new CEO and got good news from FDA, which enabled the stock price to bounce 20% in 2 days.
Here we got this inside day after such a big movement, so the direction it broke becomes so important to the following sentiment on this name.
Trading this inside day directly is also an OK idea, but I would more like to find intraday trade in 5/15/30 minute chart as I don't really want to swing this name unless I have a very successful day-trade.
*For educational use only
